The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Policies & Impacts

27 Drugs Will Be Cheaper for Medicare Recipients From April

27 Drugs Will Be Cheaper for Medicare Recipients From April
Xavier Becerra, secretary of Health and Human Services (HHS), speaks during a press conference at the HHS headquarters in Washington, on June 28, 2022. Nicholas Kamm/AFP via Getty Images
Naveen Athrappully
Naveen Athrappully
Reporter
3/16/2023|Updated: 3/16/2023
0:00

Some beneficiaries of Medicare could start paying less for 27 prescription drugs from next month as their prices have exceeded the rate of inflation.

“Today, the Department of Health and Human Services [HHS], through the Centers for Medicare & Medicaid Services (CMS), announced 27 prescription drugs for which Part B beneficiary coinsurances may be lower from April 1—June 30, 2023,” said a March 15 CMS press release. “Some people with Medicare who take these drugs may save between $2 and $390 per average dose starting April 1, depending on their individual coverage.”

Naveen Athrappully
Naveen Athrappully
Reporter
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Author’s Selected Articles
Small Business Administration Set to Remove 628 Companies From Development Program
Mar 05, 2026
Small Business Administration Set to Remove 628 Companies From Development Program
Oil Is ‘Beginning to Flow’ From Venezuela, Trump Says
Mar 05, 2026
Oil Is ‘Beginning to Flow’ From Venezuela, Trump Says
Americans in UAE, Qatar, Saudi Arabia, Israel Urged to Register for Departure Assistance
Mar 04, 2026
Americans in UAE, Qatar, Saudi Arabia, Israel Urged to Register for Departure Assistance
China Remains No. 1 Source of Counterfeit Products Globally: Report
Mar 04, 2026
China Remains No. 1 Source of Counterfeit Products Globally: Report
Related Topics
Medicare
prescription drugs
drug pricing
Inflation Reduction Act of 2022
medicare drugs
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.